GlassScriptPhysician profile
Laura C Price
NPI 1225269657
$2,081.24
in general payments reported to CMS, 2019-2025
21 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $429 · 2023: $16.29 · 2024: $184 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624 · Travel and Lodging: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.89 |
| Travel and Lodging | $614.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $866.69 | 2024-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Teleflex LLC | $234.97 | 2021-2023 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $217.56 | 2024-2025 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $122.31 | 2022 | |
| Medtronic, INC. | $92.31 | 2021 | |
| Allergan, INC. | $86.61 | 2021 | |
| Astellas Pharma US INC | $73.13 | 2021-2022 | |
| Merz North America, INC. | $47.18 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.90 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $40.60 | 2021-2022 | |
| Urogen Pharma, INC. | $32.50 | 2025 | |
| Abbvie INC. | $28.68 | 2022 | |
| Edwards Lifesciences Corporation | $26.91 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $24.43 | 2022 | |
| Merck Sharp & Dohme LLC | $22.50 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $22.28 | 2025 | Gemtesa |
| Laborie Medical Technologies Corp. | $21.86 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $20.55 | 2022 | |
| Clarus Therapeutics INC. | $19.00 | 2021 | |
| Solventum Corporation | $17.28 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Corcept Therapeutics | $16.99 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.